JP Morgan Call 215 PGR 16.08.2024/ DE000JB9P636 /
6/20/2024 10:37:53 AM | Chg.-0.050 | Bid6:31:31 PM | Ask6:31:31 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.820EUR | -5.75% | 0.840 Bid Size: 50,000 |
0.860 Ask Size: 50,000 |
Progressive Corporat... | 215.00 USD | 8/16/2024 | Call |
GlobeNewswire
3:00 PM
New Innovative Schema Features Expand Capabilities of Fauna’s Document-Relational Database
GlobeNewswire
3:00 PM
CAST and LIRIS collaborate to apply advanced graph visualization algorithms for understanding comple...
GlobeNewswire
2:30 PM
Kearny Financial Corp. Names Chief Operating Officer and Chief Financial Officer
GlobeNewswire
2:00 PM
Spinogenix Announces Approval from the Australia Human Research Ethics Committee to Initiate a Phase...
GlobeNewswire
7:30 AM
OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of I...
GlobeNewswire
6/13
Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...
GlobeNewswire
6/12
Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...
GlobeNewswire
6/12
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire
6/11
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire
6/11
Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...
GlobeNewswire
6/11
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...
GlobeNewswire
6/10
LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire
6/10
SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
GlobeNewswire
6/7
TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
6/7
Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...
GlobeNewswire
6/6
Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple...
GlobeNewswire
6/6
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...